<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00354237</url>
  </required_header>
  <id_info>
    <org_study_id>DGS2005/0130</org_study_id>
    <nct_id>NCT00354237</nct_id>
  </id_info>
  <brief_title>DARE: Diabetes in cArdiac REhabilitation</brief_title>
  <official_title>Effect of Strict Glycemic Control on Improvement of Exercise Capacities (VO2 Peak, Peak Workload After Cardiac Rehabilitation, in Patients With Type 2 Diabetes Mellitus With Coronary Artery Disease.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the DARE study is to see whether strict glycemic control during cardiac
      rehabilitation may ameliorate the improvement of exercise capacities (VO2 peak, peak
      workload, ventilatory threshold)in patients with type 2 diabetes with coronary artery
      disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a recent study, we showed that the benefit of cardiac rehabilitation on the improvement of
      exercise capacities (VO2 peak, peak workload, ventilatory threshold), after an acute coronary
      event, was significantly reduced in patients with type 2 diabetes. Moreover ,we showed, in
      multivariate analysis, that the worse improvement of the capacities to the effort after
      cardiac rehabilitation, was mainly related to hyperglycemia.

      Because the improvement of exercise capacities after cardiac rehabilitation (in particular
      VO2 peak) has been shown to be an essential factor to reduce short- term and long-term
      morbidity and mortality, we may think that such benefit on reduction of morbidity and
      mortality may be significantly less in patients with diabetes.

      Thus, we propose to carry out a multicentric intervention study, entitled DARE which goal is
      to see whether a strict glycemic control, during cardiac rehabilitation following an acute
      Myocardial Infarction (MI), is likely to improve, the results of cardiac rehabilitation on
      exercise capacities in patients with type 2 diabetes.

      After arrival in cardiac rehabilitation, patients with diabetes, will be randomized into 2
      groups: an &quot;intensive treatment&quot; group, in which the patients will treated by insulin under a
      basal-bolus regimen with strict glycemic control and a &quot;conventional treatment&quot; group, in
      which the previous anti-diabetic treatment will be continued.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2005</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>improvement of peak VO2,</measure>
    <time_frame>at the beginning and at the end of the cardiac rehabilitation programm</time_frame>
    <description>Effect of strict glycemic control during cardiac rehabilitation on improvement of peak VO2.For this purpose, we paln to compare first the 2 treatment groups (intensive vs. control) and second, 2 pre-specified glycemic control groups according to the final fructosamine level (below and above the median).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of patients, in each group of treatment, having improved from at least 16% their peak VO2, after cardiac rehabilitation.</measure>
    <time_frame>at the beginning and at the end of the cardiac rehabilitation programm</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>study of the influence of improvement of glycemic control on the results of cardiac rehabilitation on exercise capacities (peak of VO2, peak workload , ventilatory threshold).</measure>
    <time_frame>at the beginning and at the end of the cardiac rehabilitation programm</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>improvement of ventilatory threshold</measure>
    <time_frame>from the beginning and at the end of the cardiac rehabilitation programm</time_frame>
    <description>Effect of strict glycemic control during cardiac rehabilitation on improvement of ventilatory threshold</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>No intensive treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intensive insulin treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional antidiabetic treatment</intervention_name>
    <description>No intensive treatment</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intensive insulin treatment</intervention_name>
    <description>Intensive insulin treatment</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes mellitus

          -  recent Miocardial Infarction

          -  HbA1c above 7%

          -  enrolled in a cardiac rehabilitation program

        Exclusion Criteria:

          -  Type 1 diabetes

          -  Coronary Bypass Surgery

          -  Renal Failure (creatinine clearance below 30 ml/min)

          -  severe Respiratory Failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruno L Vergès, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire Dijon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre hospitalier du pays d'Aix</name>
      <address>
        <city>Aix en Provence</city>
        <zip>13616</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Rhône Durance</name>
      <address>
        <city>Avignon</city>
        <zip>84082</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital J Minjoz</name>
      <address>
        <city>Besancon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CMC Bligny</name>
      <address>
        <city>Briis Sous Forges</city>
        <zip>91640</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>centre de réadaptation cardiaque &quot;Château le moine&quot;</name>
      <address>
        <city>Cenon</city>
        <zip>33150</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU du Bocage</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre IRIS</name>
      <address>
        <city>Marcy l'Etoile</city>
        <zip>69280</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de MONTBARD</name>
      <address>
        <city>Montbard</city>
        <zip>21506</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital BROUSSAIS, APHP</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital du haut Lévêque</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rééducation cardiovasculaire CRF Kerpape</name>
      <address>
        <city>Ploemeur</city>
        <zip>56275</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital jeanne d'arc</name>
      <address>
        <city>Toul</city>
        <zip>54201</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 19, 2006</study_first_submitted>
  <study_first_submitted_qc>July 19, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2006</study_first_posted>
  <last_update_submitted>November 17, 2014</last_update_submitted>
  <last_update_submitted_qc>November 17, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 18, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Dijon</investigator_affiliation>
    <investigator_full_name>Prof. Bruno Vergès</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>diabetes mellitus</keyword>
  <keyword>cardiac rehabilitation</keyword>
  <keyword>insulin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Hypoglycemic Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

